home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

235.31 -3.74 (-1.56%)

Official Closing Price Updated: 7:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

IQVIA HOLDINGS INC (NYSE:IQV) Reports Q3 2025 Earnings Beat and Positive Market Reaction ↗

October 28, 2025

IQVIA Q3 2025 earnings beat EPS estimates with $3.00 per share. Revenue grew 5.2% to $4.10B. The company reaffirmed its strong full-year 2025 guidance.

Via Chartmill

Topics Earnings

IQVIA (NYSE:IQV) Beats Q3 Sales Expectations

October 28, 2025

Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s...

Via StockStory

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

IQVIA Reports Third-Quarter 2025 Results

October 28, 2025

From IQVIA Holdings Inc.

Via Business Wire

IQVIA (IQV) Reports Earnings Tomorrow: What To Expect

October 26, 2025

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday morning. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

3 Healthcare Stocks Walking a Fine Line

October 24, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

October 21, 2025

From IQVIA

Via Business Wire

Why IQVIA (IQV) Stock Is Trading Up Today

October 20, 2025

Shares of clinical research company IQVIA (NYSE: IQV) jumped 3.6% in the afternoon session after Bank of America raised its price target on the company's shares to $230 from $215. The adjustment from...

Via StockStory

Topics Artificial Intelligence

3 Reasons to Sell IQV and 1 Stock to Buy Instead

October 10, 2025

IQVIA has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.8%. The stock now trades at $200.20, marking a 39.8% gain. This was partly thanks to its solid...

Via StockStory

Topics Stocks

This Tractor Supply Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

October 09, 2025

Via Benzinga

Looking Into IQVIA Holdings Inc's Recent Short Interest ↗

October 07, 2025

Via Benzinga

Market Minute: Fed's Dovish Pivot Amidst Softening Labor Market – What It Means for Investors

October 04, 2025

The U.S. labor market is flashing clear signs of weakness as of October 2025, prompting a significant shift in the Federal Reserve's monetary policy. With unexpected job losses and a rising...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Demystifying IQVIA Hldgs: Insights From 8 Analyst Reviews ↗

October 02, 2025

Via Benzinga

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Why IQVIA (IQV) Stock Is Trading Up Today

October 01, 2025

Shares of clinical research company IQVIA (NYSE: IQV) jumped 6.3% in the afternoon session after the company, in partnership with GSK, announced a major update to its Vaccine Track data tool for...

Via StockStory

Topics Government

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

September 30, 2025

From IQVIA Holdings Inc.

Via Business Wire

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Healthcare Sector Grapples with 5% Slump in 2025: A Deep Dive into Market Underperformance

September 24, 2025

The healthcare sector finds itself in turbulent waters in 2025, registering a concerning 5% slump and significantly lagging the overall S&P 500 index. This downturn marks a continuation of a multi-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

3 Large-Cap Stocks That Concern Us

September 22, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

September 16, 2025

From IQVIA

Via Business Wire

Why IQVIA (IQV) Stock Is Up Today

September 11, 2025

Shares of clinical research company IQVIA (NYSE: IQV) jumped 2.3% in the afternoon session after the company announced the launch of a new AI-powered platform to manage the financial aspects of...

Via StockStory

Topics Artificial Intelligence Economy

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

September 10, 2025

From IQVIA

Via Business Wire

This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

September 09, 2025

Via Benzinga

Assessing IQVIA Hldgs: Insights From 7 Financial Analysts ↗

September 09, 2025

Via Benzinga

IQVIA Announces CFO Transition in Early 2026

September 02, 2025

From IQVIA Holdings Inc.

Via Business Wire

Veeva Systems Lifts Outlook on CRM Wins ↗

August 27, 2025

Via The Motley Fool

Topics Artificial Intelligence

Firefly Stock Jumps As Nvidia Partnership Boosts AI-Driven EEG Technology For Neurological Care ↗

August 26, 2025

Firefly Neuroscience (AIFF) stock up after unveiling CLEAR Platform powered by Nvidia's (NVDA) L40S GPU for improved EEG data quality and processing speed.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com